Home » Authors » James Etheridge

Articles by James Etheridge

Neurotech Acquires Exclusive License From Amgen For CNTF

Jan. 16, 2002

By James Etheridge

Neurotech Acquires Exclusive License From Amgen For CNTF

Jan. 16, 2002

By James Etheridge

French Parliament Could Vote To Allow Therapeutic Cloning

Jan. 16, 2002

By James Etheridge

ExonHit Partners With IDEC To Develop Antibody Therapeutics

Jan. 9, 2002

By James Etheridge

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma.

ExonHit Partners With IDEC To Develop Antibody Therapeutics

Jan. 9, 2002

By James Etheridge

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma.

Crucell Unveils AdVac, Its New Genetic Vaccination Technology

June 6, 2001

By James Etheridge

Crucell Unveils AdVac, Its New Genetic Vaccination Technology

June 6, 2001

By James Etheridge

Transgene Financing Nets $54M; BioMérieux Stake Reaches 70%

May 30, 2001

By James Etheridge

Hybrigenics, Institut Curie Create Joint Cancer Research Facility

May 30, 2001

By James Etheridge

Neurotech Raises $30M Privately To Fund Work In Cell Therapies

May 30, 2001

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...